Riociguat contains not less than 98.0% and not more than 102.0% of C20H19FN8O2, calculated on the anhydrous substance.

共有 1 個藥物證書使用此成份

瑞歐擬嘌呤
Riociguat

• 申請商: 台灣荃新股份有限公司
• 適應症: 抗肺動脈高血壓
• 發證日期: 2024-02-19